EMREA — Easternmed Real Estate Capital Share Price
Last trade - 00:00- €639.43m
- €615.52m
- £22.30m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.91 | ||
| Price to Tang. Book | 0.92 | ||
| Price to Free Cashflow | 25.54 | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Mar | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | £m | 9.61 | 29.97 | 18.73 | 12.31 | 22.3 | n/a | n/a | 23.43% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | -55.28 | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Easternmed Real Estate Capital PLC is a Cyprus-based company, located in Nicosia. The Company provides products and services.
Directors
- Last Annual
- March 31st, 2023
- Last Interim
- September 30th, 2021
- Incorporated
- February 14th, 2019
- Public Since
- July 7th, 2022
- Sector
- Professional & Commercial Services
- Industry
- Industrials
- Exchange
- Cyprus Stock Exchange
- Shares in Issue
- 639,426,528
- Address
- Athienitis Centennial Building, NICOSIA, 1066
- Web
- https://emrea.eu/
- Phone
- +357 22274406
- Auditors
- Markos Drakos & Co Ltd
Similar to EMREA
AJ Green Shell
Cyprus Stock Exchange
Corado Management
Cyprus Stock Exchange
Display Art
Cyprus Stock Exchange
Efa Holdings
Cyprus Stock Exchange
First Advisory and Holdings SA
Cyprus Stock Exchange
FAQ
As of Today at 19:07 UTC, shares in Easternmed Real Estate Capital are trading at . This share price information is delayed by 15 minutes.
Shares in Easternmed Real Estate Capital last closed at and the price had moved by over the past 365 days. In terms of relative price strength the Easternmed Real Estate Capital share price has underperformed the FTSE Global All Cap Index by -8.39% over the past year.
There is no consensus recommendation for this security.
Easternmed Real Estate Capital does not currently pay a dividend.
Easternmed Real Estate Capital does not currently pay a dividend.
Easternmed Real Estate Capital does not currently pay a dividend.
To buy shares in Easternmed Real Estate Capital you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of , shares in Easternmed Real Estate Capital had a market capitalisation of €639.43m.
Here are the trading details for Easternmed Real Estate Capital:
- Country of listing: Cyprus
- Exchange: CYS
- Ticker Symbol: EMREA
Based on an overall assessment of its quality, value and momentum Easternmed Real Estate Capital is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Easternmed Real Estate Capital. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -15.03%.
As of the last closing price of , shares in Easternmed Real Estate Capital were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Easternmed Real Estate Capital PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at .
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Easternmed Real Estate Capital's directors